California Public Employees Retirement System Cytom X Therapeutics, Inc. Transaction History

California Public Employees Retirement System

$141 Billion
Q3 2024

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$6.33 - $9.91 $579,195 - $906,765	-91,500 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$6.6 - $9.0 $56,839 - $77,508	-8,612 Reduced 8.6%	91,500 $707,000
Q4 2020 Feb 02, 2021	SELL	$6.47 - $7.9 $12,293 - $15,010	-1,900 Reduced 1.86%	100,112 $656,000
Q3 2020 Nov 05, 2020	BUY	$6.55 - $8.83 $13,100 - $17,660	2,000 Added 2.0%	102,012 $678,000
Q2 2020 Aug 12, 2020	BUY	$7.4 - $14.64 $60,768 - $120,223	8,212 Added 8.95%	100,012 $833,000
Q1 2020 May 12, 2020	BUY	$3.61 - $8.6 $8,303 - $19,780	2,300 Added 2.57%	91,800 $704,000
Q4 2019 Jan 27, 2020	BUY	$5.17 - $8.91 $93,577 - $161,271	18,100 Added 25.35%	89,500 $744,000
Q3 2019 Oct 31, 2019	BUY	$7.38 - $12.25 $1,586 - $2,633	215 Added 0.3%	71,400 $527,000
Q2 2019 Aug 15, 2019	SELL	$9.35 - $11.41 $243,240 - $296,831	-26,015 Reduced 26.76%	71,185 $799,000
Q1 2019 May 03, 2019	BUY	$9.5 - $19.16 $289,598 - $584,073	30,484 Added 45.69%	97,200 $1.05 Million
Q4 2018 Feb 08, 2019	BUY	$12.69 - $18.61 $104,058 - $152,602	8,200 Added 14.01%	66,716 $1.01 Million
Q3 2018 Nov 13, 2018	BUY	$18.04 - $26.41 $1.06 Million - $1.55 Million	58,516 New	58,516 $1.08 Million

Others Institutions Holding CTMX

# of Institutions

Shares Held

50.7M

Call Options Held

112K

Put Options Held

8.3K

Tang Capital Management LLC San Diego, CA

7.81M
Shares

$8.28 Million
0.79% of portfolio
Bvf Inc San Francisco, CA

5.23M
Shares

$5.54 Million
0.2% of portfolio
Vanguard Group Inc Valley Forge, PA

5.16M
Shares

$5.47 Million
0.0% of portfolio
Janus Henderson Group PLC London, X0

4.81M
Shares

$5.1 Million
0.0% of portfolio
Acadian Asset Management LLC Boston, MA

3.1M
Shares

$3.29 Million
0.01% of portfolio

View Full List

About CytomX Therapeutics, Inc.

Ticker CTMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,950,200
Market Cap $69.9M
Description
CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...

More about CTMX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.

Account